Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Paricalcitol in Reducing Parathyroid Hormone Levels and Ameliorating Markers of Bone Remodelling in Renal Transplant Recipients With Secondary Hyperparathyroidism (APPLE)

This study has been completed.
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research Identifier:
First received: October 11, 2010
Last updated: February 21, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)